Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms

Neuroscience Letters

Volumn 562, Issue , 2014, Pages 45-49

  Cardo, Lucía F ^a   Coto, Eliecer ^a   de Mena, Lorena ^a   Ribacoba, René ^b   Mata, Ignacio F ^c,d   Menéndez, Manuel ^b   Moris, Germán ^b   Alvarez, Victoria ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Neurología Hospital Universitario Central Asturias and Álvarez Buylla Mieres   (Spain)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha synuclein isoforms; DNA polymorphisms; Genetic risk; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN 112; ALPHA SYNUCLEIN 126; ALPHA SYNUCLEIN 140; ALPHA SYNUCLEIN 98; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; OCCIPITAL CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANTIA NIGRA; VERY ELDERLY;

ALPHA-SYNUCLEIN ISOFORMS; DNA POLYMORPHISMS; GENETIC RISK; PARKINSON'S DISEASE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALTERNATIVE SPLICING; BRAIN; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; SUBSTANTIA NIGRA;

EID: 84893425589     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.009     Document Type: Article

References (20)

1. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
2. Cardo L.F., Coto E., de Mena L., Ribacoba R., Lorenzo-Betancor O., Pastor P., Samaranch L., Mata I.F., Diaz M., Moris G., Menendez M., Corao A.I., Alvarez V. A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease. J. Mol. Neurosci. 2011, 47:425-430.
3. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., Johnston J.A., Gibson J.M., Farrer M.J., Lynch T. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech. Ageing Dev. 2007, 128:378-382.
4. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Kruger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
5. Winkler S., Hagenah J., Lincoln S., Heckman M., Haugarvoll K., Lohmann-Hedrich K., Kostic V., Farrer M., Klein C. alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007, 69:1745-1750.
6. Beyer K., Ispierto L., Latorre P., Tolosa E., Ariza A. Alpha- and beta-synuclein expression in Parkinson disease with and without dementia. J. Neurol. Sci. 2011, 310:112-117.
7. Chiba-Falek O., Lopez G.J., Nussbaum R.L. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov. Disord. 2006, 21:1703-1708.
8. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K.J., Wolf B., Berg D., Mueller J.C., Gasser T. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J. 2008, 22:1327-1334.
9. Kingsbury A.E., Daniel S.E., Sangha H., Eisen S., Lees A.J., Foster O.J. Alteration in alpha-synuclein mRNA expression in Parkinson's disease. Mov. Disord. 2004, 19:162-170.
10. Hu Y., Tang B., Guo J., Wu X., Sun Q., Shi C., Hu L., Wang C., Wang L., Tan L., Shen L., Yan X., Zhang H. Variant in the 3' region of SNCA associated with Parkinson's disease and serum alpha-synuclein levels. J. Neurol. 2011, 259:497-504.
11. Linnertz C., Saucier L., Ge D., Cronin K.D., Burke J.R., Browndyke J.N., Hulette C.M., Welsh-Bohmer K.A., Chiba-Falek O. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS ONE 2009, 4:e7480.
12. Mata I.F., Shi M., Agarwal P., Chung K.A., Edwards K.L., Factor S.A., Galasko D.R., Ginghina C., Griffith A., Higgins D.S., Kay D.M., Kim H., Leverenz J.B., Quinn J.F., Roberts J.W., Samii A., Snapinn K.W., Tsuang D.W., Yearout D., Zhang J., Payami H., Zabetian C.P. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch. Neurol. 2010, 67:1350-1356.
13. McCarthy J.J., Linnertz C., Saucier L., Burke J.R., Hulette C.M., Welsh-Bohmer K.A., Chiba-Falek O. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant. Neurogenetics 2011, 12:59-64.
14. Sotiriou S., Gibney G., Baxevanis A.D., Nussbaum R.L. A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci. Lett. 2009, 461:196-201.
15. Beyer K., Domingo-Sabat M., Lao J.I., Carrato C., Ferrer I., Ariza A. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases. Neurogenetics 2008, 9:15-23.
16. Beyer K. Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol. 2006, 112:237-251.
17. Ma K.L., Song L.K., Long W.A., Yuan Y.H., Zhang Y., Song X.Y., Niu F., Han N., Chen N.H. Deletion in exon 5 of the SNCA gene and exposure to rotenone leads to oligomerization of alpha-synuclein and toxicity to PC12 cells. Brain Res. Bull. 2013, 90:127-131.
18. Rhinn H., Qiang L., Yamashita T., Rhee D., Zolin A., Vanti W., Abeliovich A. Alternative alpha-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. Nat. Commun. 2012, 3:1084.
19. McLean J.R., Hallett P.J., Cooper O., Stanley M., Isacson O. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression. Mol. Cell Neurosci. 2012, 49:230-239.
20. Westerlund M., Belin A.C., Anvret A., Hakansson A., Nissbrandt H., Lind C., Sydow O., Olson L., Galter D. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. FASEB J. 2008, 22:3509-3514.